301 Kessler Boulevard West Dr west, Indianapolis, IN 46228
Industry:
Pharmaceuticals
Work:
InnoThink Center for Research in Biomedical Innovation since Aug 2010
Chief Apostle, breakthrough innovation,
Eli Lilly and Company Dec 2002 - Jul 2010
Advisor, Corporate Strategy
Eli Lilly and Company Oct 1980 - Dec 2001
multiple positions
Education:
Paris Institute of Technology for Life, Food and Environmental Sciences
Ingénieur Agronome, Animal Science, biostatistics, Monte Carlo simulation (thesis), multivariate analysis
Stanford University Graduate School of Business
MBA, business strategy, general management
University of California, Davis
MS, Agricultural Economics, econometrics, mathematical programming, quantitative analysis
Skills:
Pharmaceutical Industry Pharmaceutics Fda Science Drug Discovery R&D Clinical Development Lifesciences Oncology Leadership Market Research Biopharmaceuticals Sales Effectiveness Business Strategy Management Biotechnology Cross Functional Team Leadership Cancer Start Ups Strategy Sales Clinical Trials Immunology Negotiation Patents Medical Devices Gcp Drug Development Cro Product Launch Regulatory Affairs Commercialization Infectious Diseases Competitive Intelligence Assay Development Clinical Research Technology Transfer Open Innovation
Interests:
Pharmaceutical Innovation Artificial Intelligence Cooking Biodefense Open Source Drug R&D New R&D Models My Kids Disruptive Innovation Network Analysis Folk Arts Blockbuster Economics Wine Metabolic Simulations
"What we are seeing is a system that was created with good intent being hijacked," said Bernard Munos, a former corporate strategy advisor at drug giant Eli Lilly and Co. who reviewed the KHN analysis of several FDA drug databases. It's "quite remarkable that it has gone on for so long."
Date: Jan 17, 2017
Category: Health
Source: Google
After 190 Tries, Are We Any Closer to a Cure for Alzheimer's?
fizer and Johnson & Johnson released results of large trials that showed their amyloid treatment didnt slow progression of the disease. All told, at least 190 Alzheimers drugs have failed in human trials, according to Bernard Munos, a senior fellow at FasterCures, a health nonprofit.
Date: Jun 27, 2016
Category: Health
Source: Google
For Valeant Pharmaceuticals, a reversal of fortune
Pearson had a point when he said theres a lot of waste, said Bernard Munos, a former corporate strategy adviser at Eli Lilly who is now a senior fellow at FasterCures, a medical research think tank. But a smarter model would not have eliminated R&D, because we still want innovation.
Date: Mar 28, 2016
Category: Business
Source: Google
The new drug dilemma: Does big pharma have a duty to humankind — or its ...
Mr. Pearson is right when he says most pharmaceutical drug R&D is wasted money, says Bernard Munos, an influential industry consultant whos long been calling for radical change in the way companies do research. But he says that doesnt mean doing R&D is inherently unproductive and cant be
Indianapolis, IN Creve Coeur, MO Palo Alto, CA Davis, CA Lisbon, Portugal Vienna, Austria Paris, France Fes, Morocco Lamotte-Beuvron, France Orléans, France
Work:
InnoThink - Founder (2010) Eli Lilly and Company - Advisor, Corporate Strategy
Education:
Stanford Graduate School of Business, University of California, Davis, Paris Institute of Technology for Life, Food and Environmental Sciences - Animal Science
Youtube
Partnerships TV: Bernard Munos, Innothink Cen...
In this session of Partnerships TV, Marc Dresner speaks with Bernard M...
Duration:
7m 15s
30-year Eli Lilly veteran Bernard Munos on ou...
Drug companies world-wide are under pressure. The rise of generics, lo...
Duration:
13m 33s
How to Advance Rejuvenation Therapies? - Bern...
Bernard Munos, senior fellow at FasterCures and founder of InnoThink, ...
Duration:
31m
2. OpenSCI 2012 -- Session 2, Bernard Munos (...
Opening Scientific Collaboration for Innovation in Global Health (Open...
Duration:
34m 13s
4. OpenSCI 2012 -- Session 2, Q&A w/ Bernard ...
Opening Scientific Collaboration for Innovation in Global Health (Open...
Duration:
15m 43s
CPEU4 - Main Stage - Bernard Munos
Bernard munos. Thank you good morning everybody a good friend of mine ...